Disclosure Information
Financial disclosure information is current as of January 2015 and forward. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.
Current Chairs
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: Dr. Bhattacharya was awarded research grants, paid to her institution, from Gilead Sciences Inc.
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: Dr. Price was awarded research grants, paid to her institution, from AbbVie, Cepheid, Gilead Sciences Inc., Merck & Co Inc., and Zydus. Spouse has interest in stock that is independently managed in AbbVie, Bristol-Myers Squibb, Johnson and Johnson, Merck.
Updated: 03/01/2025
Current Panel Members
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: Dr. Feld serves as a scientific consultant to Precision Biosciences, Vir, Roche, GlaxoSmithKline, Gilead, Bluejay Therapeutics, AbbVie, Aligos Therapeutics.
Institutional Research: Dr. Feld was awarded research grants paid to his institution from AbbVie, Atea Pharmaceuticals, Gilead, GlaxoSmithKline, Roche, and Vir.
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: Dr. Kushner serves as a consultant for Eiger, Gilead, Ipsen, Madrigal, and Mirum
Institutional Research: Dr. Kushner received research grants, paid to her institution, from Gilead, Icahn School of Medicine at Mount Sinai
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: Dr. Lim received research grants, paid to his institution from Eiger, Gilead, Intercept, Pfizer, TARGET PharmaSolutions, and Viking
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: Dr. Martin was awarded research grants, paid to her institution, from AbbVie and Gilead.
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: Ms. Searson's organization was awarded grants from AbbVie, Inc., Gilead Sciences, Inc, and Merck & Co, Inc.
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: Dr. Terrault was awarded research grants, paid to her institution, from NIH, Gilead Sciences, GSK, Roche-Genentech, Helio Health, Durect Corp., Eiger Pharmaceuticals, Madrigal.
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: Dr. Verna was awarded research grants paid to her institution from Salix Pharmaceuticals.
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: None
Updated: 03/01/2025
Personal Financial Relationships: None
Institutional Research: Dr. Workowski was awarded research grants, paid to her institution, from Gilead Sciences, Inc.
Updated: 03/01/2025